Advertisement
Screener

OMEROS CORP (OMER) Graph

OMER Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $28.53M; Cost of revenue $798.00K; Research and development $13.80M; Selling, general and administrative $13.86M.
  • 2026-03-31: Revenue $9.89M; Cost of revenue $587.00K; Research and development $13.36M; Selling, general and administrative $13.37M.
  • 2025-12-31: Revenue (m); Cost of revenue (m); Research and development $19.45M*; Selling, general and administrative $9.63M*.
  • 2025-09-30: Revenue (m); Cost of revenue (m); Research and development $15.99M; Selling, general and administrative $10.40M.

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

OMER revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Royalties OnSales Of YARTEMLEA$300.00KRevenue$28.53MCost of revenue$798.00KOperating income$74.00KResearch & development$13.80MSelling, general& administrative$13.86MPre-tax income$6.67MIncome tax$29.00KNet income$13.23M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$28.53M$798.00K$13.80M$13.86M(m)$29.00K$13.23M
2026-03-31$9.89M$587.00K$13.36M$13.37M(m)$57.00K$56.06M
2025-12-31(m)(m)$19.45M*$9.63M*(m)(m)$86.45M*
2025-09-30(m)(m)$15.99M$10.40M(m)(m)-$30.92M
2025-06-30$0.00$0.00$22.01M$10.35M(m)$0.00-$25.42M
2025-03-31$0.00$0.00$23.85M$11.12M(m)$0.00-$33.46M
2024-09-30(m)(m)$24.08M$11.32M(m)(m)-$32.23M
2024-06-30(m)(m)$45.35M$13.81M(m)(m)-$56.04M
2024-03-31(m)(m)$26.77M$12.26M(m)(m)-$37.18M
2023-09-30(m)(m)$31.73M$16.42M(m)(m)-$37.75M
2023-06-30(m)(m)$29.64M$11.26M(m)(m)-$37.29M
2023-03-31(m)(m)$24.61M$11.10M(m)(m)-$33.70M
2022-09-30(m)(m)$38.57M$12.20M(m)(m)-$17.46M
2022-06-30(m)(m)$23.52M(m)(m)(m)-$30.85M
2022-03-31(m)(m)$24.09M(m)(m)(m)-$33.01M
2021-09-30$30.00M$333.00K$25.82M(m)(m)(m)-$22.70M
2021-06-30$28.82M$342.00K$30.13M(m)(m)(m)-$28.59M
2021-03-31$21.06M$263.00K$32.50M(m)(m)(m)-$35.09M
2020-12-31$10.63M(m)(m)(m)(m)(m)-$37.27M
2020-09-30$26.11M$401.00K$31.32M(m)(m)-$7.85M-$38.46M
2020-06-30$13.53M$147.00K$24.13M(m)(m)(m)-$33.29M
2020-03-31$23.54M$267.00K$28.91M(m)(m)(m)-$29.03M
2019-12-31$33.42M(m)(m)(m)(m)(m)-$29.23M
2019-09-30$29.86M$278.00K$23.75M(m)(m)(m)-$16.46M
2019-06-30$26.75M$55.00K$19.11M(m)(m)(m)-$14.45M
2019-03-31$21.78M$131.00K$26.25M(m)$41.02M(m)-$24.34M
2018-12-31$22.02M(m)(m)(m)$40.49M(m)-$23.53M
2018-09-30$4.61M$36.00K$26.86M(m)$40.05M(m)-$39.47M
2018-06-30$1.66M$116.00K$19.41M(m)$32.27M(m)-$33.70M
2018-03-31$1.59M$203.00K$18.14M(m)$29.28M(m)-$30.05M
2017-12-31$13.76M(m)(m)(m)$27.88M(m)-$16.55M
2017-09-30$21.66M$184.00K$14.84M(m)$26.77M(m)-$7.48M
2017-06-30$17.15M(m)$13.14M(m)$29.09M(m)-$14.36M
2017-03-31$12.26M(m)$12.24M(m)$24.98M(m)-$15.09M
2016-12-31$12.90M(m)(m)(m)$24.76M(m)-$19.63M
2016-09-30$11.29M(m)$12.49M(m)$23.33M(m)-$13.96M
2016-06-30$10.00M(m)$10.23M(m)$20.93M(m)-$12.61M
2016-03-31$7.42M(m)$15.43M(m)$26.87M(m)-$20.54M
2015-12-31$6.67M(m)(m)(m)$24.71M(m)-$19.83M
2015-09-30$3.26M(m)$13.26M(m)$22.56M(m)-$19.92M
2015-06-30$3.19M(m)$10.90M(m)$19.15M(m)-$16.68M
2015-03-31$388.00K(m)$9.32M(m)$18.32M(m)-$18.67M
2014-12-31$180.00K(m)(m)(m)$20.16M(m)-$20.71M
2014-09-30$214.00K(m)$11.77M(m)$17.35M(m)-$18.33M
2014-06-30$45.00K(m)$12.41M(m)$17.26M(m)-$17.99M
2014-03-31$100.00K(m)$12.02M(m)$15.78M(m)-$16.64M
2013-12-31$169.00K(m)(m)(m)$14.07M(m)-$1.84M
2013-09-30$196.00K(m)$9.42M(m)$13.63M(m)-$13.87M
2013-06-30$140.00K(m)$9.56M(m)$13.30M(m)-$13.59M
2013-03-31$1.09M(m)$7.13M(m)$11.12M(m)-$10.49M
2012-12-31$1.58M(m)(m)(m)$9.12M(m)-$7.73M
2012-09-30$1.42M(m)$7.76M(m)$14.45M(m)-$13.28M
2012-06-30$1.53M(m)$7.56M(m)$9.77M(m)-$8.54M
2012-03-31$1.50M(m)$7.25M(m)$9.57M(m)-$8.89M
2011-12-31$1.14M(m)(m)(m)$10.99M(m)-$10.20M
2011-09-30$987.00K(m)$5.32M(m)$7.15M(m)-$6.51M
2011-06-30$1.16M(m)$4.08M(m)$6.10M(m)-$5.29M
2011-03-31$1.24M(m)$5.42M(m)$7.69M(m)-$6.54M
2010-09-30$254.00K(m)(m)(m)$7.74M(m)-$7.55M
2010-06-30$497.00K(m)(m)(m)$8.13M(m)-$7.80M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$38.42M$1.39M$27.16M$27.23M(m)$86.00K$69.29M
2025-06-30$0.00$0.00$45.85M$21.47M(m)$0.00-$58.88M
2024-06-30(m)(m)$72.12M$26.07M(m)(m)-$93.22M
2023-06-30(m)(m)$54.25M$22.36M(m)(m)-$71.00M
2022-06-30(m)(m)$47.60M(m)(m)(m)-$63.86M
2021-06-30$49.88M$606.00K$62.63M(m)(m)(m)-$63.68M
2020-06-30$37.07M$414.00K$53.04M(m)(m)(m)-$62.33M
2019-06-30$48.53M$186.00K$45.36M(m)(m)(m)-$38.80M
2018-06-30$3.24M$319.00K$37.55M(m)$61.55M(m)-$63.75M
2017-06-30$29.41M(m)$25.38M(m)$54.07M(m)-$29.45M
2016-06-30$17.42M(m)$25.66M(m)$47.80M(m)-$33.15M
2015-06-30$3.58M(m)$20.22M(m)$37.47M(m)-$35.35M
2014-06-30$145.00K(m)$24.42M(m)$33.05M(m)-$34.63M
2013-06-30$1.24M(m)$16.69M(m)$24.41M(m)-$24.08M
2012-06-30$3.02M(m)$14.80M(m)$19.34M(m)-$17.43M
2011-06-30$2.39M(m)$9.50M(m)$13.79M(m)-$11.83M
2010-06-30$875.00K(m)(m)(m)$14.93M(m)-$14.46M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30(m)(m)$61.85M$31.86M(m)(m)-$89.80M
2024-09-30(m)(m)$96.20M$37.40M(m)(m)-$125.46M
2023-09-30(m)(m)$85.98M$38.78M(m)(m)-$108.75M
2022-09-30(m)(m)$86.17M$37.08M(m)(m)-$81.32M
2021-09-30$79.89M$938.00K$88.45M(m)(m)(m)-$86.39M
2020-09-30$63.18M$815.00K$84.36M(m)(m)-$7.85M-$100.79M
2019-09-30$78.39M$464.00K$69.11M(m)(m)(m)-$55.26M
2018-09-30$7.85M$355.00K$64.41M(m)$101.60M(m)-$103.22M
2017-09-30$51.07M$613.00K$40.21M(m)$80.84M(m)-$36.93M
2016-09-30$28.71M(m)$38.16M(m)$71.13M(m)-$47.11M
2015-09-30$6.83M(m)$33.48M(m)$60.03M(m)-$55.27M
2014-09-30$359.00K(m)$36.20M(m)$50.39M(m)-$52.96M
2013-09-30$1.43M(m)$26.11M(m)$38.05M(m)-$37.95M
2012-09-30$4.44M(m)$22.57M(m)$33.79M(m)-$30.71M
2011-09-30$3.38M(m)$14.82M(m)$20.94M(m)-$18.34M
2010-09-30$1.13M(m)(m)(m)$22.68M(m)-$22.02M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31(m)(m)$81.30M$41.50M(m)$2.01M-$3.35M
2024-12-31(m)(m)$119.52M$47.43M(m)$2.31M-$156.81M
2023-12-31(m)(m)$114.87M$49.66M(m)$0.00-$117.81M
2022-12-31(m)(m)$112.72M$50.67M(m)$0.00$47.42M
2021-12-31(m)(m)$118.78M$54.84M(m)$0.00$194.24M
2020-12-31$73.81M$902.00K$107.61M(m)(m)-$23.26M-$138.06M
2019-12-31$111.81M$865.00K$106.32M(m)(m)-$19.77M-$84.49M
2018-12-31$29.87M$512.00K$89.86M(m)$142.09M-$12.93M-$126.76M
2017-12-31$64.83M$1.08M$55.60M(m)$108.72M$0.00-$53.48M
2016-12-31$41.62M$1.41M$50.70M(m)$95.89M$0.00-$66.75M
2015-12-31$13.51M(m)$48.38M(m)$84.75M(m)-$75.10M
2014-12-31$539.00K(m)$47.95M(m)$70.55M(m)-$73.67M
2013-12-31$1.60M(m)$36.30M(m)$52.12M(m)-$39.80M
2012-12-31$6.02M(m)$31.92M(m)$42.91M(m)-$38.44M
2011-12-31$4.52M(m)$23.72M(m)$31.93M(m)-$28.55M
2010-12-31$2.10M(m)$23.46M(m)$32.21M(m)-$29.25M
2009-12-31$1.44M(m)$16.93M(m)$22.20M(m)-$21.09M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Ultragenyx Pharmaceutical Inc. (RARE)United States$1.456B-5.62
ArriVent BioPharma, Inc. (AVBP)United States$1.485B-10.25
Innoviva, Inc. (INVA)United States$1.493B4.62
Oric Pharmaceuticals, Inc. (ORIC)United States$1.367B-8.00
ANAPTYSBIO, INC (ANAB)United States$1.546B-60.20
Kailera Therapeutics, Inc. (KLRA)United States$1.552B
Kardigan, Inc. (KARD)United States$1.346B
Tyra Biosciences, Inc. (TYRA)United States$1.337B-12.83
Bicara Therapeutics Inc. (BCAX)United States$1.309B-10.55
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82